In this edition:
Targeted therapy initiation & symptomatic treatments in PsA
Depression/anxiety & remission in rheumatoid arthritis/PsA
‘Difficult-to-manage’ PsA definition
Retention of TNFis vs. IL-17/23is in axPsa
ARGO: sonelokimab for PsA
TAK-279 for PsA
Biological treatments for prevention of PsA
Course of degenerative spinal changes in axSpA
Pain intensity in axSpA
Semen quality in PsA & axSpA
Please login below to download this issue (PDF)